Close
Back to VXRT Stock Lookup

(VXRT) – PRNewswire

Oct 26, 2021 08:00 AM Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial
Oct 7, 2021 04:13 PM New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model
Oct 6, 2021 08:00 AM Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial
Sep 27, 2021 08:00 AM Vaxart Appoints Dr. James F. Cummings as Chief Medical Officer
Sep 22, 2021 04:05 PM Vaxart To Present at Upcoming Vaccine Conferences
Sep 21, 2021 04:15 PM Vaxart Announces Creation of Manufacturing and Quality Advisory Board
Sep 20, 2021 08:00 AM Vaxart to Present at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30
Sep 7, 2021 04:20 PM Vaxart to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 23, 2021 09:00 AM Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
Aug 19, 2021 04:02 PM Vaxart Announces Creation of New Scientific and Clinical Advisory Board
Aug 5, 2021 04:02 PM Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
Aug 2, 2021 08:00 AM FDA Clears Vaxart's IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate
Jul 29, 2021 08:22 AM Vaxart Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine
Oct 7, 2020 08:02 AM Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates
Oct 7, 2020 08:00 AM Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates
May 20, 2020 07:58 AM Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Back to VXRT Stock Lookup